Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Portenoy

Showing results (151-160 of 354) with videos related to

Pageof 36
Sort By:
Pain|December 1, 1990
The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusionsRussell K Portenoy, Kathleen M Foley, Charles E Inturrisi
Current Medical Research and Opinion|January 9, 2007
Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled studyRussell K Portenoy, John Messina, Fang Xie, et al.
Current Treatment Options in Oncology|March 22, 2022
Family Meetings in Palliative Care: Benefits and BarriersMyra Glajchen, Anna Goehring, Hannah Johns, et al.
Pain Medicine (Malden, Mass.)|September 3, 2010
A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic painJohn T Farrar, John Messina, Fang Xie, et al.
Pain|August 31, 2010
A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer painRussell K Portenoy, Allen W Burton, Nashat Gabrail, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Opioids and the treatment of chronic pain: controversies, current status, and future directionsAndrew Rosenblum, Lisa A Marsch, Herman Joseph, et al.
Schmerz (Berlin, Germany)|January 1, 1995
[Pharmacotherapy of cancer pain : 2. Use of opioids.]N I Cherny, R K Portenoy, M Raber, et al.
Journal of Pain and Symptom Management|October 18, 2015
Initial Validation of the Daily Spiritual Experiences Scale in Chinese Immigrants With Cancer PainGraciete Lo, Jack Chen, Thomas Wasser, et al.
Journal of Opioid Management|May 21, 2010
Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of lifeRussell K Portenoy, Daniel Bruns, Bonnie Shoemaker, et al.
Schmerz (Berlin, Germany)|March 1, 1995
[Pharmacotherapy of cancer pain. 3. Adjuvant drugs.]N I Cherny, R K Portenoy, M Raber, et al.
Pageof 36

Showing results (151-160 of 354) with videos related to

Sort By:
Pageof 36
Pain|December 1, 1990
The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusionsRussell K Portenoy, Kathleen M Foley, Charles E Inturrisi
Current Medical Research and Opinion|January 9, 2007
Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled studyRussell K Portenoy, John Messina, Fang Xie, et al.
Current Treatment Options in Oncology|March 22, 2022
Family Meetings in Palliative Care: Benefits and BarriersMyra Glajchen, Anna Goehring, Hannah Johns, et al.
Pain Medicine (Malden, Mass.)|September 3, 2010
A novel 12-week study, with three randomized, double-blind placebo-controlled periods to evaluate fentanyl buccal tablets for the relief of breakthrough pain in opioid-tolerant patients with noncancer-related chronic painJohn T Farrar, John Messina, Fang Xie, et al.
Pain|August 31, 2010
A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer painRussell K Portenoy, Allen W Burton, Nashat Gabrail, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Opioids and the treatment of chronic pain: controversies, current status, and future directionsAndrew Rosenblum, Lisa A Marsch, Herman Joseph, et al.
Schmerz (Berlin, Germany)|January 1, 1995
[Pharmacotherapy of cancer pain : 2. Use of opioids.]N I Cherny, R K Portenoy, M Raber, et al.
Journal of Pain and Symptom Management|October 18, 2015
Initial Validation of the Daily Spiritual Experiences Scale in Chinese Immigrants With Cancer PainGraciete Lo, Jack Chen, Thomas Wasser, et al.
Journal of Opioid Management|May 21, 2010
Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of lifeRussell K Portenoy, Daniel Bruns, Bonnie Shoemaker, et al.
Schmerz (Berlin, Germany)|March 1, 1995
[Pharmacotherapy of cancer pain. 3. Adjuvant drugs.]N I Cherny, R K Portenoy, M Raber, et al.
Pageof 36